Literature DB >> 15950986

SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy.

Timothy J Nelson1, Robert Balza, Qi Xiao, Ravi P Misra.   

Abstract

Serum response factor (SRF) is a transcription factor required for the regulation of genes important for cardiac structure and function. Notably, the "fetal gene expression profile" that is characteristic of cardiac hypertrophy consists of genes known to be regulated by SRF. Transgenic animal studies suggest that cardiac-specific overexpression of SRF induces this pattern of hypertrophic genes and subsequently causes the progression of pathologic adaptations. Furthermore, studies examining cardiac tissues from patients with severe heart failure indicate significant alterations in SRF expression that correspond with alterations in expression of SRF-dependent genes. Based on these observations, it has been postulated that SRF may be critical for stimulating pathologic gene expression at the onset of hypertrophic adaptation. To address the role of SRF in cardiac hypertrophy we investigated whether SRF is necessary and sufficient for the expression of genes associated with the hypertrophic response. We used isolated cardiomyocytes from both neonatal rats, and transgenic mice containing floxed SRF alleles, to examine cardiac gene expression in response to overexpression and absence of SRF. Using this approach, we demonstrate that SRF is required for the induction of atrial naturetic factor (ANF), c-fos, NCX1, BNP, alpha-actins, alpha-myosin heavy chain, and beta-myosin heavy chain genes. However, overexpression of exogenous SRF in isolated cardiomyocytes is only sufficient to induce NCX1 and alpha-myosin heavy chain. These results indicate that SRF is critical for the regulation and induction of genes associated with the progression of pathologic cardiac hypertrophy, however, the pattern of genes induced by overexpression of SRF in isolated cardiomyocytes is different from those genes expressed in hypertrophic transgenic hearts. This suggests that SRF-dependent gene expression is modulated in a complex manner by in vivo physiologic systems prior to and during heart failure as the organism adapts to cardiac stress.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15950986     DOI: 10.1016/j.yjmcc.2005.05.004

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  40 in total

1.  Serum response factor binding sites differ in three human cell types.

Authors:  Sara J Cooper; Nathan D Trinklein; Loan Nguyen; Richard M Myers
Journal:  Genome Res       Date:  2007-01-02       Impact factor: 9.043

2.  microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart.

Authors:  Ning Liu; Svetlana Bezprozvannaya; Andrew H Williams; Xiaoxia Qi; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Genes Dev       Date:  2008-11-17       Impact factor: 11.361

3.  ZFP260 is an inducer of cardiac hypertrophy and a nuclear mediator of endothelin-1 signaling.

Authors:  Hiba Komati; Wael Maharsy; Janie Beauregard; Salim Hayek; Mona Nemer
Journal:  J Biol Chem       Date:  2010-11-04       Impact factor: 5.157

4.  Non-targeted metabolomics of Brg1/Brm double-mutant cardiomyocytes reveals a novel role for SWI/SNF complexes in metabolic homeostasis.

Authors:  Ranjan Banerjee; Scott J Bultman; Darcy Holley; Carolyn Hillhouse; James R Bain; Christopher B Newgard; Michael J Muehlbauer; Monte S Willis
Journal:  Metabolomics       Date:  2015-10-01       Impact factor: 4.290

5.  Cleavage of serum response factor mediated by enteroviral protease 2A contributes to impaired cardiac function.

Authors:  Jerry Wong; Jingchun Zhang; Bobby Yanagawa; Zongshu Luo; Xiangsheng Yang; Jiang Chang; Bruce McManus; Honglin Luo
Journal:  Cell Res       Date:  2011-07-19       Impact factor: 25.617

6.  Regulation of Ncx1 expression. Identification of regulatory elements mediating cardiac-specific expression and up-regulation.

Authors:  Lin Xu; Ludivine Renaud; Joachim G Müller; Catalin F Baicu; D Dirk Bonnema; Hongming Zhou; Christiana S Kappler; Steven W Kubalak; Michael R Zile; Simon J Conway; Donald R Menick
Journal:  J Biol Chem       Date:  2006-09-10       Impact factor: 5.157

7.  Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy.

Authors:  Ding-Sheng Jiang; Zhou-Yan Bian; Yan Zhang; Shu-Min Zhang; Yi Liu; Rui Zhang; Yingjie Chen; Qinglin Yang; Xiao-Dong Zhang; Guo-Chang Fan; Hongliang Li
Journal:  Hypertension       Date:  2013-04-15       Impact factor: 10.190

8.  Eccentric exercise activates novel transcriptional regulation of hypertrophic signaling pathways not affected by hormone changes.

Authors:  Lauren G MacNeil; Simon Melov; Alan E Hubbard; Steven K Baker; Mark A Tarnopolsky
Journal:  PLoS One       Date:  2010-05-18       Impact factor: 3.240

9.  Calpain 2 activation of P-TEFb drives megakaryocyte morphogenesis and is disrupted by leukemogenic GATA1 mutation.

Authors:  Kamaleldin E Elagib; Jeremy D Rubinstein; Lorrie L Delehanty; Valerie S Ngoh; Peter A Greer; Shuran Li; Jae K Lee; Zhe Li; Stuart H Orkin; Ivailo S Mihaylov; Adam N Goldfarb
Journal:  Dev Cell       Date:  2013-12-23       Impact factor: 12.270

10.  Prox1 maintains muscle structure and growth in the developing heart.

Authors:  Catherine A Risebro; Richelle G Searles; Athalie A D Melville; Elisabeth Ehler; Nipurna Jina; Sonia Shah; Jacky Pallas; Mike Hubank; Miriam Dillard; Natasha L Harvey; Robert J Schwartz; Kenneth R Chien; Guillermo Oliver; Paul R Riley
Journal:  Development       Date:  2008-12-17       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.